Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study.
- Resource Type
- Article
- Authors
- Kay, Jonathan; Jaworski, Janusz; Wojciechowski, Rafal; Wiland, Piotr; Dudek, Anna; Krogulec, Marek; Jeka, Slawomir; Zielinska, Agnieszka; Trefler, Jakub; Bartnicka-Maslowska, Katarzyna; Krajewska-Wlodarczyk, Magdalena; Klimiuk, Piotr A.; Lee, Sang Joon; Bae, Yun Ju; Yang, Go Eun; Yoo, Jae Kyoung; Furst, Daniel E.; Keystone, Edward
- Source
- Arthritis Research & Therapy; 2/5/2021, Vol. 23 Issue 1, p1-12, 12p
- Subject
- Language
- ISSN
- 14786354